Sales rise 16.94% to Rs 1087.51 crore
Net profit of Strides Pharma Science reported to Rs 70.20 crore in the quarter ended June 2024 as against net loss of Rs 7.11 crore during the previous quarter ended June 2023. Sales rose 16.94% to Rs 1087.51 crore in the quarter ended June 2024 as against Rs 929.99 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales1087.51929.99 17 OPM %18.8714.37 -PBDT137.5165.89 109 PBT88.916.30 1311 NP70.20-7.11 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
